Dynavax stock price is heating up....If the FDA lifts the clinical hold....
and there are a myriad of scenarios surrounding that,,,the stock should have
material upside,,,,,in any event , the market cap is so low relative to their
drug discovery platform,,,,it remains one of THE best risk/reward stocks that
I have seen......
Anyone else following this company??........
P.s......Does anyone think the GSK deal in december augers for a potential
larger deal on the Hep B drug which would be a direct competitor against
GSK's engerix??